Pressroom: Press Releases


NIH Awards $15.9 Million to CCNY and Memorial Sloan Kettering to Create Partnership to Address Cancer Disparities

The National Institutes of Health’s National Cancer Institute has awarded The City College of New York and Memorial Sloan Kettering Cancer Center a $15.9 million grant to implement a unique partnership in cancer research, education, and outreach.

February 25, 2009
Nominations Sought for Paul Marks Prize

Nominations are currently being sought for the Paul Marks Prize for Cancer Research.

February 3, 2009
Why Cancer Drugs Are So Expensive and Why Medicare Can't Fix the Problem

A new health policy report which will be published in the New England Journal of Medicine suggests that the swift and dramatic rise in cancer-drug spending is due to laws that keep Medicare from managing the use or price of cancer drugs. These laws limit Medicare’s actions in cancer far more than they are limited in other areas of healthcare.

January 27, 2009
Childhood Cancer Survivors Not Following Recommended Breast Cancer Screening Guidelines

The majority of young women at an increased risk of breast cancer due to chest radiation treatment for childhood cancer are not following breast cancer screening recommendations, according to a recently released, detailed assessment appearing in the January 28, 2009, issue of the Journal of the American Medical Association.

January 27, 2009
Research Shows Cell's Inactive State is Critical for Effectiveness of Cancer Treatment

A new study sheds light on a little understood biological process called quiescence, which enables blood-forming stem cells to exist in a dormant or inactive state in which they are not growing or dividing. According to the study’s findings, researchers identified the genetic pathway used to maintain a cell’s quiescence, a state that allows bone marrow cells to escape the lethal effects of standard cancer treatments.

January 9, 2009


Researchers Create Smaller, Brighter Probe, Tailored for Clinical Molecular Imaging and Tumor Targeting

Researchers have developed a new generation of microscopic particles for molecular imaging, constituting one of the first promising nanoparticle platforms that may be readily adapted for tumor targeting and treatment in the clinic.

December 22, 2008
New Geoffrey Beene Gift to Memorial Sloan Kettering Puts Total Support Over $100 Million

Memorial Sloan Kettering Cancer Center has announced the gift of a membership interest in Geoffrey Beene, LLC, the company that controls the business and fashion empire created by legendary designer Geoffrey Beene.

October 9, 2008
New Study Examines Effectiveness of Colorectal Cancer Screening Tests and Suggests Screening May Be Stopped at Age 75

New findings from a Decision Analysis for the US Preventative Services Task Force (USPSTF) suggest that routine colorectal cancer screenings can be stopped in patients over the age of 75.

October 6, 2008
Innovative Relationship Advances Cancer Care in New Jersey

Memorial Sloan Kettering Cancer Center and Summit Medical Group together announce a new collaborative relationship for the care of people with cancer.

October 2, 2008
American Tennis Star James Blake to Launch Cancer Research Fund in His Father's Name at Memorial Sloan Kettering Cancer Center

American tennis player and World No. 8 ranked James Blake will formally announce today the launch of the Thomas Blake, Sr., Memorial Research Fund, which he established to support cancer research at Memorial Sloan Kettering Cancer Center.

July 10, 2008
Acupuncture Reduces Pain and Dysfunction in Head and Neck Cancer Patients after Neck Dissection

New data from a randomized, controlled trial found that acupuncture provided significant reductions in pain, dysfunction, and dry mouth in head and neck cancer patients after neck dissection.

May 31, 2008
Drug Fends Off Kidney Cancer Progression

New data from an international, multicenter Phase III clinical trial has found that the experimental targeted therapy everolimus (RAD001) significantly delays cancer progression in patients with metastatic kidney cancer whose disease had worsened on other treatments.

May 16, 2008
Researchers Learn How Signaling Molecule Orchestrates Breast Cancer's Spread

A study led by researchers at Memorial Sloan Kettering Cancer Center has uncovered how breast tumors use a particular type of molecule to promote metastasis - the spread of cancer cells.

April 3, 2008
Therapeutic Cloning Treats Parkinson's Disease in Mice

Research led by investigators at Memorial Sloan Kettering Cancer Center has shown that therapeutic cloning, also known as somatic-cell nuclear transfer (SCNT), can be used to treat Parkinson’s disease in mice.

March 23, 2008
At Home Genomic Tests for Disease Risk Premature

The recent marketing of “at home” genomic tests for disease risk may be premature, according to Dr. Kenneth Offit, MD, MPH, Chief of the Clinical Genetics Service at Memorial Sloan Kettering Cancer Center (MSKCC).

March 18, 2008
Cardiac Effects Associated with Breast Cancer Treatment Appear Lower with Dose-Dense Delivery of Conventional Chemotherapy

A new pilot study by investigators at Memorial Sloan Kettering Cancer Center found that breast cancer patients can be treated safely with a “dose-dense” regimen of standard chemotherapy agents and the antibody trastuzumab (Herceptin®), a drug that has previously been shown to cause cardiac toxicity.

March 6, 2008
Researchers Identify New Genetic Marker for Breast Cancer

An international group of investigators led by scientists at Memorial Sloan Kettering Cancer Center and the National Cancer Institute has identified a new genetic marker of risk for breast cancer. Women with this DNA variation are at a 1.4 times greater risk of developing breast cancer compared to those without the variation.

March 3, 2008
Novel Mechanism Found That May Boost Impaired Function of Leukemia Protein

A new study led by researchers at Memorial Sloan Kettering Cancer Center (MSKCC) reports on a novel mechanism that can enhance the function of a protein that is frequently impaired in patients with acute forms of leukemia.

February 29, 2008
PSA Testing Can Predict Advanced Prostate Cancer

A single prostate specific antigen (PSA) test taken before the age of 50 can be used to predict advanced prostate cancer in men up to 25 years in advance of a diagnosis, according to a new study published by researchers at Memorial Sloan Kettering Cancer Center in New York and Lund University in Sweden.

February 14, 2008
Benefit of Cancer Prevention Surgery Differs Between Women with BRCA1 and BRCA2 Mutations

The surgical removal of the ovaries has been widely adopted as a cancer-risk-reducing strategy for women with either BRCA1 or BRCA2 mutations. A new multicenter study led by researchers at Memorial Sloan Kettering Cancer Center is the first prospective examination of the impact of this procedure in which BRCA2 mutation carriers were analyzed separately from BRCA1 mutation carriers.

February 11, 2008
Syndicate content